Premium
Validating sugar‐sweetened beverage intake and adiposity among African‐American and White adults in a doubly labeled water study
Author(s) -
Emond Jennifer A.,
Patterson Ruth E,
Jardack Patricia M,
Arab Lenore
Publication year - 2012
Publication title -
the faseb journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.709
H-Index - 277
eISSN - 1530-6860
pISSN - 0892-6638
DOI - 10.1096/fasebj.26.1_supplement.258.3
Subject(s) - overweight , medicine , obesity , logistic regression , caloric intake , zoology , demography , biology , sociology
Evidence is mixed regarding sugar‐sweetened beverage (SSB) intake and adiposity among adults. To look at the effect of reporting bias, we compared SSB intake and overweight/obese status (BMI ≥25 kg/m 2 ) among adults in a dietary assessment and doubly labeled water study (n=250). Four web‐based, 24‐hour recalls assessed dietary intake. SSB intake was categorized as none, 1–99 kcals/day, or >99 kcals/day; 99 kcals/day was median SSB intake among consumers. Logistic regression models, adjusted for total caloric intake, age, race, education and diet quality, compared SSB intake to overweight/obese status. We repeated analyses in a subset of “true reporters”: those with self‐reported total caloric intake within 25% of total energy expenditure per doubly labeled water (n=108). One‐half of participants were overweight/obese; more overweight/obese participants drank SSB than normal weight participants (69% vs. 47%; p<0.001). Intake of other beverages did not differ by adiposity. Compared to no intake, SSB intake up to the median doubled the risk of being overweight/obese (OR: 2.1, 95% CI: 1.0–4.3; p=0.046), and SSB intake over the median more than doubled the risk (OR: 2.6, 95% CI: 1.2–6.0; p=0.018). When limited to true reporters, SSB intake significantly increased the risk of being overweight/obese by nearly 4 fold. Results support that SSB consumption increases the risk of being overweight/obese among adults. This funding for this project was provided by the National Institutes of Health grant R01CA105048, as well as training grant T32 GM084896.Grant Funding Source : Training grant T32 GM084896
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom